First Patients Treated in Yokohama, Japan Following Expanded Japanese Regulatory Approval SUNNYVALE, Calif ., March 19 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the first extracranial patients were treated in
SUNNYVALE, Calif. , July 19, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Joseph E. Whitters to the company's Board of Directors, effective as of July 16, 2018 . In addition, he will serve on the Board's Audit Committee. With Mr.
SUNNYVALE, Calif. , Oct. 15, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that Kelly Londy , formerly chief commercial officer has been named chief operating officer of the Company effective immediately. Ms. Londy will also remain an executive vice president of the
Succeeds Retiring CFO Greg Lichtwardt SUNNYVALE, Calif. , Sept. 15, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that Kevin Waters , formerly Senior Vice President, Finance, has been promoted to Chief Financial Officer of the Company effective as of today. He
SUNNYVALE, Calif. and LANCASTER, Pa. , Feb. 24, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) and Lancaster General Health announced today that the first commercially available InCise™ Multileaf Collimator (MLC) for the CyberKnife ® M6™ System has been received by Lancaster .
- Royal Brisbane and Women's Hospital acquisition is intended to expand access to potentially life-saving radiotherapy treatments to more patients - Hospital was the first in Australia to invest in the TomoTherapy® helical radiotherapy delivery platform and is now the first to secure the latest
Recently Published Data Demonstrate Benefits of CyberKnife Treatment for Both Low- and Intermediate-Risk Patients at Five Years Post-Treatment SUNNYVALE, Calif. , Sept. 25, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that published data from two prospective,
SUNNYVALE, Calif. , Feb. 11, 2014 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that overall user satisfaction for its TomoTherapy ® System has increased for the fifth consecutive quarter, according to the Q4 2013 MD Buyline Market Intelligence Briefing™.
SUNNYVALE, Calif. , July 17, 2014 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that its CyberKnife ® and TomoTherapy ® Systems have received the highest composite overall user satisfaction rating among radiation treatment delivery systems in the U.S., according to the Q2 2014
Installation at Burdenko Institute of Neurosurgery will be Accuray's Second in Russia SUNNYVALE, Calif., Aug. 7 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the Burdenko Institute of Neurosurgery in Moscow has
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
